Applied therapeutics supports 15th annual rare disease day

New york, feb. 28, 2022 (globe newswire) -- applied therapeutics, inc. (nasdaq: aplt), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, today is recognizing the 15th annual rare disease day to help elevate awareness of rare diseases and call attention to the unique challenges facing people with rare diseases.
APLT Ratings Summary
APLT Quant Ranking